Sinovac COVID-19 vaccine: all 25 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 VaccinesCompletedNCT05668065Phase 3
- Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and AboveCompletedNCT05381350Phase 3
- SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer PatientsCompletedNCT05313074Not applicable
- Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 VaccineCompletedNCT05303584Phase 4
- Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 YearsCompletedNCT05137418Phase 3
- Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 YearsActive, not recruitingNCT05112913Phase 4
- Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)Status unknownNCT05087368Phase 2
- Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19Status unknownNCT05079217Phase 4
- Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)CompletedNCT05057169Phase 4
- Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and AdolescentsCompletedNCT04992208Phase 4
- Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine BoosterStatus unknownNCT04992182Phase 2
- Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy AdultsStatus unknownNCT04962308Phase 4
- Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in AdultsCompletedNCT04911790Phase 4
- Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy AdultsCompletedNCT04894227Phase 4
- Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and AdolescentsCompletedNCT04884685Phase 2
- Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant RecipientsStatus unknownNCT04801667Phase 4
- Covid-19 Vaccination in Adolescents and ChildrenActive, not recruitingNCT04800133Phase 2
- Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for SeverityStatus unknownNCT04789356Phase 4
- Antibody Response to COVID-19 Vaccines in Liver Disease PatientsCompletedNCT04775069Phase 4
- A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19Status unknownNCT04756830Phase 4
- COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDSCompletedNCT04754698Phase 4
- An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) VaccineCompletedNCT04747821Phase 4
- Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in AdultsCompletedNCT04651790Phase 3
- Clinical Trial For SARS-CoV-2 Vaccine (COVID-19)CompletedNCT04582344Phase 3
- Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare ProfessionalsCompletedNCT04456595Phase 3